Article Details

AstraZeneca shares rise after trial success of its breast cancer drug | This is Money

Retrieved on: 2022-08-15 12:27:52

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca shares rise after trial success of its breast cancer drug | This is Money. View article details on hiswai:

Excerpt

AstraZeneca's drug targets patients with HER2-positive metastatic breast cancer. In its 600-patient trial called DESTINY-Breast02, Enhertu was ...

Article found on: www.thisismoney.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up